Allison Marie Lowe , APRN
Nurse Practitioner • Jacksonville Beach, FL
390 16th Ave S
Jacksonville Beach, FL 322504961
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 15, 2012; this date does not establish years in practice.
-
Published CMS data list 951 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trazodone Hcl — 103 prescription fills, including refills.
- Quetiapine Fumarate — 78 prescription fills, including refills.
- Clonazepam — 57 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 26 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner in Jacksonville Beach, FL (2024, 13 clinicians with data). Median for this group: 783. Middle half: 365 to 1,152.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,448 in 2020 to 951 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
390 16th Ave S
Jacksonville Beach, FL 322504961
NPPES lists 1 additional practice-address record in Jacksonville, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,215 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$107,451 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,755.77 across 79 records.
By nature of payment
- Food and Beverage: $1,743.90 across 78 records.
- Education: $11.87 across 1 record.
Reporting-company totals (3 largest of 14)
- Vanda Pharmaceuticals Inc.: $289.28 across 11 records.
- Otsuka America Pharmaceutical, Inc.: $197.66 across 9 records.
- Teva Pharmaceuticals USA, Inc.: $191.51 across 10 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2012
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Allison Lowe has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Allison Lowe as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Jacksonville Beach and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner in Jacksonville Beach, FL (2024, 13 clinicians with data). Median for this group: 783. Middle half: 365 to 1,152.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Nurse Practitioner in Jacksonville Beach, FL (2024, 13 clinicians with data). Median for this group: $50,258. Middle half: $7,014 to $122,908.
A higher Part D drug cost than 70% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: $18,227. Middle half: $1,370 to $130,581.
19 active clinicians are listed under Nurse Practitioner with a practice address in Jacksonville Beach, FL (8,853 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Jacksonville Beach
52.6% of these 19 clinicians have the CMS telehealth indicator.
73.7% of these 19 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 34% from 1,448 in 2020 to 951 in 2024.
- 2020: 1,448
- 2021: 123
- 2022: 186
- 2023: 546
- 2024: 951
-
30-day fills
30-day fills decreased 47% from 2,289 in 2020 to 1,215 in 2024.
- 2020: 2,289
- 2021: 173
- 2022: 209
- 2023: 669
- 2024: 1,215
-
Part D drug cost
Part D drug cost decreased 50% from $213,015 in 2020 to $107,451 in 2024.
- 2020: $213,015
- 2021: $3,228
- 2022: $169,007
- 2023: $262,147
- 2024: $107,451
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 57% from $1,117.88 in 2021 to $1,755.77 in 2025.
- 2021: $1,117.88
- 2022: $835.52
- 2023: $2,326.11
- 2024: $2,315.27
- 2025: $1,755.77
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 79 records totaling $1,755.77.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
FANAPT | General | $93.02 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $37.79 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $36.85 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $32.12 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $31.09 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $29.95 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $29.57 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $28.63 |
| Almatica Pharma LLC |
Food and Beverage
In-kind items and services
|
LOREEV XR | General | $28.58 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $28.32 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $28.27 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
TRINTELLIX | General | $28.05 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $27.98 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $26.60 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $26.48 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
INVEGA SUSTENNA | General | $26.20 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $25.97 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $25.90 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $25.67 |
| Almatica Pharma LLC |
Food and Beverage
In-kind items and services
|
LOREEV XR | General | $25.65 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $25.58 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $25.29 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $25.10 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $25.09 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $25.04 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trazodone Hcl | Trazodone Hcl | 103 | 4,274 | $522.96 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 78 | 3,259 | $1,610.74 | 14 |
| Clonazepam | Clonazepam | 57 | 1,558 | $451.29 | 12 |
| Alprazolam | Alprazolam | 56 | 1,578 | $501.90 | — |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | 1,586 | $311.72 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 51 | 2,100 | $701.56 | 11 |
| Lamotrigine | Lamotrigine | 50 | 1,932 | $353.54 | 11 |
| Buspirone Hcl | Buspirone Hcl | 47 | 1,845 | $665.97 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | 1,590 | $153.23 | — |
| Escitalopram Oxalate | Escitalopram Oxalate | 38 | 1,500 | $283.83 | — |
| Lithium Carbonate | Lithium Carbonate | 38 | 1,394 | $91.10 | — |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 38 | 1,403 | $605.26 | 12 |
| Sertraline Hcl | Sertraline Hcl | 37 | 1,830 | $125.43 | — |
| Mirtazapine | Mirtazapine | 37 | 1,470 | $336.90 | — |
| Bupropion Xl | Bupropion Hcl | 33 | 1,890 | $847.46 | 16 |
| Lurasidone Hcl | Lurasidone Hcl | 33 | 1,117 | $12,746.84 | — |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 30 | 930 | $688.57 | — |
| Prazosin Hcl | Prazosin Hcl | 18 | 780 | $247.43 | — |
| Rexulti | Brexpiprazole | 18 | 540 | $29,789.31 | — |
| Lorazepam | Lorazepam | 17 | 389 | $20.39 | — |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | 688 | $758.31 | — |
| Gabapentin | Gabapentin | 12 | 540 | $184.12 | — |
| Risperidone | Risperidone | 12 | 420 | $188.73 | — |
| Abilify Maintena | Aripiprazole | 12 | 354 | $35,491.49 | — |
| Vraylar | Cariprazine Hcl | 12 | 360 | $19,454.59 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-04-26NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
NUCC Taxonomy Code: 363LF0000X
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20120731000751
FL
0244496586
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Secondary Practice Locations
2377 Dunn Ave, Ufjax - Dept. Of Chfm/dunn Avenue Family Medicine
Jacksonville, FL 322186983
Phone: 9046330700
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Nurse Practitioner (license number reported to NPPES: FL ARNP 9220821)
Registered at 390 16TH AVE S, JACKSONVILLE BEACH, FL 322504961 (Tel: 9043953899)
Registered at 8550 TOUCHTON RD APT 333, JACKSONVILLE, FL 322161189
Recorded as ALLISON LOWE, APRN
Nurse Practitioner (license number reported to NPPES: FL APRN9220821)
NPI status registered as active in NPPES database
Registered at 2377 DUNN AVE, UFJAX - DEPT. OF CHFM/DUNN AVENUE FAMILY MEDICINE, JACKSONVILLE, FL 322186983 (Tel: 9046330700)
Registered at PO BOX 44008, UFJP - PROVIDER ENROLLMENT, JACKSONVILLE, FL 322314008 (Tel: 9042443199)
Recorded as ALLISON LOWE, ARNP
Nurse Practitioner (license number reported to NPPES: FL ARNP 9220821)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Jacksonville Beach
- Danielle O'brien, APRN
- Jennifer Murphy, ARNP
- Anna Gutierrez, FNP
- Lindsay Vines, APRN
- Antonette Arevalo, APRN
- Nicole Thomas, APRN
Mailing Address
8550 Touchton Rd Apt 333
Jacksonville, FL 322161189
Phone: 9048531195